Clara Chepkirui

Clara Chepkirui

Auto-generated profile, based on publicly available information

Clara Chepkirui

Institute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zurich

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2024 in Science
Verified
Journal Article
Closed access
MMMathijs F. J. Mabesoone
Mathijs F. J. Mabesoone
SLStefan Leopold-Messer
Stefan Leopold-Messer
HMHannah A. Minas
Hannah A. Minas
CCClara Chepkirui
Clara Chepkirui
PCPornsuda Chawengrum
Pornsuda Chawengrum
JPJörn Piel
Jörn Piel
Bacterial multimodular polyketide synthases (PKSs) are giant enzymes that generate a wide range of therapeutically important but synthetically challenging natural products. Diversification of polyketide structures can be achieved by engineering these enzymes. However, notwithstanding successes made with textbook cis -acyltransferase ( cis -AT) PKSs, tailoring such large assembly lines remains challenging. Unlike textbook PKSs, trans -AT PKSs feature an extraordinary diversity of PKS modules and commonly evolve to form hybrid PKSs. In this study, we analyzed amino acid coevolution to identify a common module site that yields functional PKSs. We used this site to insert and delete diverse PKS parts and create 22 engineered trans -AT PKSs from various pathways and in two bacterial producers. The high success rates of our engineering approach highlight the broader applicability to generate complex designer polyketides.

16 July 2019 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CCClara Chepkirui
Clara Chepkirui
TCTian Cheng
Tian Cheng
WSWinnie Chemutai Sum
Winnie Chemutai Sum
JMJosphat Matasyoh
Josphat Matasyoh
CDCony Decock
Cony Decock
Marc StadlerMarc Stadler
Marc Stadler

18 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
VVVera Vollenweider
Vera Vollenweider
KRKaroline Rehm
Karoline Rehm
CCClara Chepkirui
Clara Chepkirui
MPManuela Pérez-Berlanga
Manuela Pérez-Berlanga
MPMagdalini Polymenidou
Magdalini Polymenidou
RKRolf Kümmerli
Rolf Kümmerli
The global rise of antibiotic resistance calls for new drugs against bacterial pathogens. A common approach is to search for natural compounds deployed by microbes to inhibit competitors. Here we show that the iron chelating pyoverdines, siderophores produced by environmental Pseudomonas spp., have strong antibacterial properties by inducing iron starvation and growth arrest in pathogens. A screen of 320 natural Pseudomonas isolates used against 12 human pathogens uncovered several pyoverdines with particularly high antibacterial properties and distinct chemical characteristics. The most potent pyoverdine effectively reduced growth of the pathogens Acinetobacter baumannii , Klebsiella pneumoniae and Staphylococcus aureus in a concentration- and iron-dependent manner. Pyoverdine increased survival of infected Galleria mellonella host larvae, and showed low toxicity for the host, mammalian cell lines, and erythrocytes. Furthermore, experimental evolution combined with whole-genome sequencing revealed reduced potentials for resistance evolution compared to an antibiotic. Thus, pyoverdines from environmental strains have the potential to become a new class of sustainable antibacterials against specific human pathogens.

8 November 2024 in eLife preprints
Verified
Preprint
Open access
VVVera Vollenweider
Vera Vollenweider
KRKaroline Rehm
Karoline Rehm
CCClara Chepkirui
Clara Chepkirui
MPManuela Pérez-Berlanga
Manuela Pérez-Berlanga
MPMagdalini Polymenidou
Magdalini Polymenidou
RKRolf Kümmerli
Rolf Kümmerli
The global rise of antibiotic resistance calls for new drugs against bacterial pathogens. A common approach is to search for natural compounds deployed by microbes to inhibit competitors. Here we show that the iron chelating pyoverdines, siderophores produced by environmental Pseudomonas spp., have strong antibacterial properties by inducing iron starvation and growth arrest in pathogens. A screen of 320 natural Pseudomonas isolates used against 12 human pathogens uncovered several pyoverdines with particularly high antibacterial properties and distinct chemical characteristics. The most potent pyoverdine effectively reduced growth of the pathogens Acinetobacter baumannii, Klebsiella pneumoniae and Staphylococcus aureus in a concentration- and iron-dependent manner. Pyoverdine increased survival of infected Galleria mellonella host larvae, and showed low toxicity for the host, mammalian cell lines, and erythrocytes. Furthermore, experimental evolution combined with whole-genome sequencing revealed reduced potentials for resistance evolution compared to an antibiotic. Thus, pyoverdines from environmental strains have the potential to become a new class of sustainable antibacterials against specific human pathogens.